What is MiNK Therapeutics, Inc. Common Stock's Market Cap?

MiNK Therapeutics, Inc. Common Stock's Market Cap is $54.7M, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's Enterprise Value?

MiNK Therapeutics, Inc. Common Stock's Enterprise Value is $45.8M, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's EV / EBITDA?

MiNK Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's Net Income (TTM)?

MiNK Therapeutics, Inc. Common Stock's Net Income (TTM) is -$11.4M, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's EBITDA?

MiNK Therapeutics, Inc. Common Stock's EBITDA is -$11.8M, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

MiNK Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.23, based on as-reported figures from SEC (XBRL) filings.

What is MiNK Therapeutics, Inc. Common Stock's Net Debt?

MiNK Therapeutics, Inc. Common Stock's Net Debt is -$8.8M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

MiNK Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG012J84WM7

10.71▲ 0.65 (6.46%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 10.06
Day's Range: 10.18 – 11.68
52-Week Range: 8.46 – 16.94
Volume: 29.4K
Avg Volume: 18.6K

Share Statistics

Shares Outstanding
Employees: 15
Exchange: XNAS
Listed: 2021-10-15

Share count as of August 11, 2026

MiNK Therapeutics, Inc. Common Stock (INKT) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about MiNK Therapeutics, Inc. Common Stock (INKT)

What is MiNK Therapeutics, Inc. Common Stock's Market Cap?: MiNK Therapeutics, Inc. Common Stock's Market Cap is $54.7M, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's Enterprise Value?: MiNK Therapeutics, Inc. Common Stock's Enterprise Value is $45.8M, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's EV / EBITDA?: MiNK Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's Net Income (TTM)?: MiNK Therapeutics, Inc. Common Stock's Net Income (TTM) is -$11.4M, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's EBITDA?: MiNK Therapeutics, Inc. Common Stock's EBITDA is -$11.8M, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: MiNK Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.23, based on as-reported figures from SEC (XBRL) filings.
What is MiNK Therapeutics, Inc. Common Stock's Net Debt?: MiNK Therapeutics, Inc. Common Stock's Net Debt is -$8.8M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · INKTAs-filed SEC (XBRL) data